Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medifast (MED) Return on Sales (2016 - 2025)

Medifast's Return on Sales history spans 16 years, with the latest figure at 0.24% for Q4 2025.

  • For Q4 2025, Return on Sales fell 25.0% year-over-year to 0.24%; the TTM value through Dec 2025 reached 0.05%, down 5.0%, while the annual FY2025 figure was 0.05%, 5.0% down from the prior year.
  • Return on Sales reached 0.24% in Q4 2025 per MED's latest filing, down from 0.03% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.12% in Q1 2021 to a low of 0.24% in Q4 2025.
  • Average Return on Sales over 5 years is 0.04%, with a median of 0.08% recorded in 2022.
  • The largest YoY upside for Return on Sales was 7bps in 2025 against a maximum downside of -25bps in 2025.
  • A 5-year view of Return on Sales shows it stood at 0.09% in 2021, then decreased by -13bps to 0.08% in 2022, then crashed by -60bps to 0.03% in 2023, then tumbled by -79bps to 0.01% in 2024, then tumbled by -3804bps to 0.24% in 2025.
  • Per Business Quant, the three most recent readings for MED's Return on Sales are 0.24% (Q4 2025), 0.03% (Q3 2025), and 0.02% (Q2 2025).